Search for the latest oncology news by tumour type
Over the past decade, the approval of immune checkpoint inhibitors has revolutionised treatment for patients…
Adding the targeted therapy drug ribociclib to hormonal (endocrine) therapy showed a significant improvement in…
A new clinical trial is testing the effectiveness of chemotherapy treatment following surgery for a…
A major impediment to treating the deadly brain cancer glioblastoma has been that the most…
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute, has been awarded a…
The Food and Drug Administration has granted accelerated approval to epcoritamab-bysp for relapsed or refractory…
A pioneering radiotherapy treatment developed at Peter Mac is emerging as a new treatment option…
Inflammatory fatty liver disease (NASH, non-alcoholic steatohepatitis ) and the resulting liver cancer are driven…
A new research perspective was published in Oncotarget Volume 14 on May 10, 2023, entitled, “HER3- A key…
Peter Mac Medical Oncologist Dr Prachi Bhave explained that the research project will analyse a…